Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Rosse

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
HDAC Inhibitors as Targeted Treatment of Frontotemporal Lobar DegenerationGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel pyrroles as nicotinic acetylcholine receptor modulatorsGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Anabaseine analogues as modulators of nicotinic acetylcholine receptorGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Diphenylpropane Derivatives as Agonist of PPAR Nuclear ReceptorsGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Imidazopyrazine Derivatives As Inhibitors of mTORGerard Rosse
ACS Medicinal Chemistry Letters|February 21, 2019
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System DiseasesGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel indolethylbenzamides for the treatment of tauopathies: patent highlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Quinolinones as Activators of AMP Activated Protein Kinase: Patent HighlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Compositions and methods for the treatment of mitochondrial diseases: patent highlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolites of the pyrimidine amine preladenant as adenosine a2a receptor antagonistsGerard Rosse
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
ACS Medicinal Chemistry Letters|June 6, 2014
HDAC Inhibitors as Targeted Treatment of Frontotemporal Lobar DegenerationGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel pyrroles as nicotinic acetylcholine receptor modulatorsGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Anabaseine analogues as modulators of nicotinic acetylcholine receptorGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Diphenylpropane Derivatives as Agonist of PPAR Nuclear ReceptorsGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Imidazopyrazine Derivatives As Inhibitors of mTORGerard Rosse
ACS Medicinal Chemistry Letters|February 21, 2019
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System DiseasesGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel indolethylbenzamides for the treatment of tauopathies: patent highlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Quinolinones as Activators of AMP Activated Protein Kinase: Patent HighlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Compositions and methods for the treatment of mitochondrial diseases: patent highlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolites of the pyrimidine amine preladenant as adenosine a2a receptor antagonistsGerard Rosse
Pageof 9